• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆和尿液中血管紧张素转换酶抑制剂的放射酶分析法

Radioenzymatic assay of angiotensin-converting enzyme inhibitors in plasma and urine.

作者信息

Swanson B N, Stauber K L, Alpaugh W C, Weinstein S H

出版信息

Anal Biochem. 1985 Aug 1;148(2):401-7. doi: 10.1016/0003-2697(85)90245-3.

DOI:10.1016/0003-2697(85)90245-3
PMID:2998222
Abstract

A rapid, sensitive assay for angiotensin-converting enzyme (ACE) inhibitors is described. Biological samples were diluted with methanol to precipitate endogenous ACE and centrifuged. Supernatants were further diluted with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer, pH 8. Diluted samples were incubated at 37 degrees C with the substrate [3H]hippurylglycylglycine and rabbit lung ACE for 45 min. Acid (1.0 N HCl) was then added, and the product, [3H]hippuric acid, was extracted into a water-immiscible scintillation cocktail. Drug standards were prepared in the biological matrix to correct for drug recovery. A computer program was used to convert radioactivity (dpm) to units of enzyme activity and then correlate enzyme activity with drug concentration. The ester prodrugs fosenopril and enalapril could be assayed down to 4 ng/ml in plasma after ester hydrolysis with NaOH. Drug disposition studies in rats, dogs, and monkeys have demonstrated that the method can be readily adapted to any ACE inhibitor and is suitable for determining drug bioavailability and pharmacokinetics.

摘要

本文描述了一种快速、灵敏的血管紧张素转换酶(ACE)抑制剂检测方法。生物样品用甲醇稀释以沉淀内源性ACE,然后离心。上清液用pH 8的4-(2-羟乙基)-1-哌嗪乙磺酸缓冲液进一步稀释。稀释后的样品在37℃下与底物[3H]马尿酰甘氨酰甘氨酸和兔肺ACE孵育45分钟。然后加入酸(1.0 N HCl),产物[3H]马尿酸被萃取到与水不混溶的闪烁液中。在生物基质中制备药物标准品以校正药物回收率。使用计算机程序将放射性(dpm)转换为酶活性单位,然后将酶活性与药物浓度相关联。用氢氧化钠进行酯水解后,血浆中福辛普利和依那普利酯前药的检测下限可达4 ng/ml。在大鼠、狗和猴子身上进行的药物处置研究表明,该方法可轻松适用于任何ACE抑制剂,适用于测定药物生物利用度和药代动力学。

相似文献

1
Radioenzymatic assay of angiotensin-converting enzyme inhibitors in plasma and urine.血浆和尿液中血管紧张素转换酶抑制剂的放射酶分析法
Anal Biochem. 1985 Aug 1;148(2):401-7. doi: 10.1016/0003-2697(85)90245-3.
2
Direct determination of angiotensin-converting enzyme inhibitors in plasma by radioenzymatic assay.用放射酶分析法直接测定血浆中的血管紧张素转换酶抑制剂。
Clin Chem. 1987 Apr;33(4):549-53.
3
Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril.
Pharm Res. 1989 Dec;6(12):1043-7. doi: 10.1023/a:1015978420797.
4
An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluids.一种用于测定生物流体中血管紧张素转换酶抑制剂的优化荧光酶法。
J Pharm Biomed Anal. 1988;6(3):241-51. doi: 10.1016/0731-7085(88)80050-5.
5
Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.年龄与血管紧张素转换酶抑制剂依那普利和依那普利拉的药代动力学
Br J Clin Pharmacol. 1986 Apr;21(4):341-8. doi: 10.1111/j.1365-2125.1986.tb05205.x.
6
Radioimmunoassay for the quantitation of lisinopril and enalaprilat.赖诺普利和依那普利拉定量的放射免疫测定法。
J Pharm Sci. 1986 May;75(5):512-6. doi: 10.1002/jps.2600750518.
7
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).七种结构各异的血管紧张素转换酶(ACE)抑制剂作用的体外、离体和体内比较。
Br J Clin Pharmacol. 1989;28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. doi: 10.1111/j.1365-2125.1989.tb03587.x.
8
Determination of the angiotensin converting enzyme inhibitor benazeprilat in plasma and urine by an enzymic method.用酶法测定血浆和尿液中的血管紧张素转换酶抑制剂苯那普利拉。
J Chromatogr. 1988 Mar 18;425(2):353-61. doi: 10.1016/0378-4347(88)80039-2.
9
Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.福辛普利、赖诺普利和依那普利在慢性肾功能不全患者中的稳态药代动力学比较。
Clin Pharmacokinet. 1991 May;20(5):420-7. doi: 10.2165/00003088-199120050-00006.
10
Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.不同血管紧张素转换酶(ACE)抑制剂对缺血性离体大鼠心脏的影响:心脏ACE抑制与心脏保护之间的关系。
J Pharmacol Exp Ther. 1991 Jun;257(3):919-29.

引用本文的文献

1
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.福辛普利拉与依那普利拉和赖诺普利在充血性心力衰竭和慢性肾功能不全患者中的药代动力学比较。
Br J Clin Pharmacol. 2000 Jan;49(1):23-31. doi: 10.1046/j.1365-2125.2000.00103.x.
2
The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.福辛普利在血液透析患者中的药代动力学和药效学
Eur J Clin Pharmacol. 1993;45(5):431-6. doi: 10.1007/BF00315514.
3
Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients.
福辛普利在慢性非卧床腹膜透析患者中的药代动力学和药效学
Eur J Clin Pharmacol. 1991;41(2):165-9. doi: 10.1007/BF00265911.
4
Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.福辛普利、赖诺普利和依那普利在慢性肾功能不全患者中的稳态药代动力学比较。
Clin Pharmacokinet. 1991 May;20(5):420-7. doi: 10.2165/00003088-199120050-00006.
5
Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension.福辛普利。对其药效学和药代动力学特性以及在原发性高血压治疗中的潜力的综述。
Drugs. 1992 Jan;43(1):123-40. doi: 10.2165/00003495-199243010-00009.